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Evidence of Breed-dependent Differences in Susceptibility to Porcine
Circovirus Type–2-associated Disease and Lesions
T. OPRIESSNIG, M. FENAUX, P. THOMAS, M. J. HOOGLAND, M. F. ROTHSCHILD, X. J. MENG,
AND P. G. HALBUR
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary
Medicine, Iowa State University, Ames, IA (TO, PT, MJH, PGH); Department of Biomedical
Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, College of
Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA (MF, XJM);
and Department of Animal Science and Center for Integrated Animal Genomics, Iowa State University,
Ames, IA (MFR)
Abstract. Porcine circovirus type 2 (PCV2) has been confirmed as the primary cause of postweaning
multisystemic wasting syndrome (PMWS). However, in the field, PMWS is seen only in a small
percentage of pigs infected with PCV2. The overall objective of the study reported here was to determine
whether host genetic differences in the susceptibility to PCV2-associated disease exist among selected
breeds of pigs. This study included Duroc (n 5 23), Landrace (n 5 19), and Large White (n 5 21) pigs.
The pigs were infected intranasally and intramuscularly at 5–7 weeks of age with PCV2. A portion of the
pigs (31/63; 30.2%) had low passively acquired PCV2 antibodies at the time of infection. There were no
differences in mean weight gain, rectal temperature, or respiratory score. Clinical disease compatible
with PMWS was observed only in the Landrace pigs. Most of the PCV2-infected pigs had enlarged
lymph nodes, and individual Duroc and Landrace pigs had mottled tan lungs. PCV2-associated
lymphoid depletion and granulomatous inflammation were observed in pigs of all breeds. Three of 19
Landrace pigs and none of the Duroc or Large White pigs developed severe lymphoid lesions associated
with large amounts of intralesional PCV2 antigen typical of PMWS. Compared with seronegative
Landrace pigs, Landrace pigs that had low maternal antibodies at the time of PCV2 inoculation had
significantly (P , 0.05) less-severe PCV2-associated lesions. The results suggest a predisposition of the
Landrace pigs of this study to PCV2-induced disease and lesions, and that low levels of passively
acquired antibodies are protective.
Key words: Breed; Duroc; Landrace; Large White; porcine circovirus type 2; postweaning
multisystemic wasting syndrome; susceptibility.
Porcine circovirus (PCV) was first detected as
a contaminant of a continuous porcine kidney cell
line in 197470 and was further described in 1982.69
In the late 1990s, PCV was associated with
postweaning multisystemic wasting syndrome
(PMWS).18 Further analysis of the virus documen-
ted two distinct types of PCV: nonpathogenic type
1 (PCV1) and pathogenic and PMWS-associated
type 2 (PCV2).6,46,50 Subsequently, PCV2 has been
associated with several other swine diseases in-
cluding porcine respiratory disease complex,31
reproductive disorders characterized by abortions
with mummified fetuses,73 enteritis,38 and porcine
dermatitis and nephropathy syndrome.63 PMWS
was first observed in a Canadian herd in 1991,28
and is now recognized worldwide.1 The syndrome is
characterized by a clinical history of wasting or
poor performance in weaned pigs and by severe
lymphoid depletion and histiocytic replacement of
follicles in lymphoid tissues.66 Detection of PCV2
antigen or nucleic acids within characteristic
microscopic lesions is required for the diagnosis
of PMWS.66
Serologic surveys indicate high prevalence of
PCV2 in the swine population16,17,34,44,72; however,
the prevalence of PCV2-associated disease seems to
vary considerably from farm to farm and country
to country. Morbidity attributable to PMWS
reportedly varies from as little as 4% to as high
as 30%, and mortality in affected pigs is typically
70–80%.1,28,43,61 However, most reports to date lack
important additional information regarding breed,
production style, and environment of the farm, or
description of other diseases present in the pigs that
may have influenced expression and outcome of
PCV2-associated diseases. Genetic analyses to date
have not been able to document major differences
between PCV2 isolates recovered from affected pigs
Vet Pathol 43:281–293 (2006)
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and those from nonaffected pigs.12,42 Analysis and
comparison of PCV2 isolates from severely affected
countries like Spain or France with those from
countries that are less affected like the United
States20,45 have failed to explain differences in
clinical manifestations of PCV2-associated dis-
eases. All isolates sequenced and compared so far
indicated nucleic acid sequence homology
.94%.20,45
Experimental PCV2 infection models indicate
that PCV2 is an opportunist, depending on
immunostimulation3,39 or coinfecting agents like
porcine parvovirus (PPV),7,36,40,52 porcine reproduc-
tive and respiratory syndrome virus (PRRSV),2,32,64
or Mycoplasma hyopneumoniae54 for PCV2 infec-
tion to progress to clinical PMWS. Although most
research groups were not able to induce clinical
disease in pigs inoculated singularly with PCV2,
some groups have succeeded in this regard.8,32
PMWS was recently induced in conventional
colostrum-fed pigs singularly infected with
PCV2.41 The exact reasons for the different out-
comes in experimental PCV2 infection models are
not known, but there are several possible explana-
tions including differences in environmental condi-
tions and stressors, age of the pigs at infection, or
differences in type and dose and routes of the PCV2
inoculation.
One other aspect that, to the authors’ knowl-
edge, has not been investigated is the influence of
host genetics on PCV2 infection. Differences in
genetic susceptibility of populations or breeds to
parasites, bacteria, and viruses have been re-
ported.9,10,30,68 Evidence exists for pig breed-de-
pendent differences in disease resistance for a vari-
ety of pathogens including pseudorabies virus,59
PRRSV,27 Escherichia coli,15,49 and Sarcocystis
miescheriana.60 Pigs of all breeds seem to be
susceptible to PCV2 infection, and PMWS has
been observed within a large variety of purebred
and crossbred pigs submitted to a US diagnostic
laboratory (P.G. Halbur, unpublished data). Re-
cently, PMWS has been reported in Eurasian wild
boars in Canada19 and Spain.71 Retrospective
studies indicate that naturally acquired PCV2
infections in pig herds date back for at least
20 years prior to the first observation of
PMWS25,44,65,72; however, PCV2-associated diseases
emerged in the late 1990s. Allan et al.5 reported
experimental induction of PMWS in colostrum-
deprived Northern Ireland Landrace/Large White
crossbred pigs inoculated with a PCV2 isolate
recovered in 1993 from a subclinically infected
Swedish Yorkshire pig, implying host and/or
environmental dependant factors associated with
the development of PMWS. A recent in vitro study
investigating the replication patterns of PCV2 in
pulmonary alveolar macrophages indicated clear
differences among macrophages derived from
different conventional crossbred pigs that were
suggestive of differences in susceptibility to PCV2-
associated disease.47
The overall objective of the study reported here
was to determine whether there is evidence for host
genetic differences in susceptibility to PCV2-asso-
ciated disease among selected breeds including
Duroc, Landrace, and Large White. These breeds
were selected because they could be purchased from
a single source.
Materials and Methods
Animal source
Seventy-five purebred (n 5 26 Duroc; n 5 25
Landrace; and n 5 24 Large White), colostrum-fed,
female pigs raised under identical conditions on the
same farm and in the same barn were purchased
from a herd that is routinely tested for major swine
pathogens and is free of PRRSV and M. hyopneumoniae.
There was no evidence of PCV2-associated disease in
the source herd or in the multiplier herds supplied
by this source. The source herd is routinely vaccinated
against PPV infection and leptospirosis. The pigs
were born within a range of 23 days, randomly
selected on farm after blocking by sire and litter, weaned
at 10–12 days of age, and transported in two groups
of 39 (n 5 12 Duroc; n 5 14 Landrace; and n 5 13
Large White) and 36 (n 5 14 Duroc; n 5 11 Landrace;
and n 5 11 Large White) pigs 2 weeks apart to
the Livestock Infectious Disease Isolation Facility at
Iowa State University, Ames, Iowa. The pigs of the
various breeds were housed in two rooms until in-
oculation.
Serologic testing
Blood samples were collected at arrival of the pigs,
followed by blood collections at 2-week intervals until
the day of PCV2 inoculation. Thereafter, blood was
collected on postinoculation day (PID) 7, 14, 21, 28, and
35. Preinoculation sera (from arrival up to PID 0) and
serum samples obtained on PID 21 and 35 were tested
by a PCV2-enzyme linked immunosorbent assay
(ELISA) that is based on the recombinant ORF2
capsid protein of PCV2.51 Results were considered
positive if the calculated sample-to-positive ratio (S : P)
was $0.2.
The serum samples obtained on arrival of the pigs at
the research facility and the serum samples obtained at
necropsy from 11 randomly selected PCV2-infected pigs
of each of the three breeds were tested for the presence
of antibodies to PRRSV by use of a PRRSV-ELISA
(IDEXX Laboratories, Inc. Westbrook, MA), and for
the presence of antibodies to PPV by use of a hemag-
glutination-inhibition assay.48
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Experimental design and PCV2 inoculation
Twelve pigs (three Duroc, six Landrace, and three
Large White pigs) were kept as sham-inoculated, control
pigs and were housed together in a separate room. These
pigs were procedural controls, selected on the basis of
presence of maternal antibodies to PCV2. Experimen-
tally induced PCV2 in the remaining 63 pigs (23 Duroc,
19 Landrace, and 21 Large White pigs) was initiated
after waning of the PCV2 maternal antibody levels
below the negative cutoff (S : P ,0.2). All of the PCV2-
infected pigs were housed in three rooms and were
randomly distributed into two to seven pens of five to
six pigs per pen. The procedural controls were housed
separately in a fourth room. To account for and
minimize sire and litter effects, a minimum of four sires
were represented within each breed and two to five
piglets were chosen from each dam. The sire and dam
distribution in the PCV2-inoculated pigs was as follows:
Duroc pigs (n 5 23) represented four sires and eight
dams, and the Landrace (n 5 19) and the Large White
(n 5 21) pigs represented four sires and six dams,
respectively.
PCV2 isolate ISU-4089520 was obtained via direct
transfection of PK-15 cells with an infective clone of
PCV2 as described.21 Passage 4 of the virus at a titer of
104.2 50% tissue culture-infective doses was used for
inoculation of the pigs. The inoculum tested negative for
the presence of porcine parvovirus and PCV1 nucleic
acids on the basis of results of polymerase chain reaction
(PCR) analysis.20,37 After production, the PCV2 in-
oculum was stored in individual 50-ml tubes at 280uC
and thawed only once immediately prior to inoculation.
To better ensure infection of all pigs at the time of
inoculation, each pig received 1 ml of the PCV2
inoculum intranasally and 0.5 ml intramuscularly in
the right side of the neck as described.22,23 On the day of
PCV2 inoculation, the pigs were 5–8 weeks old. Mean 6
SE age was 43.5 6 1.8 days for the Duroc, 48.6 6
2.0 days for the Landrace, and 46.0 6 2.0 days for the
Large White pigs.
Clinical evaluation
After PCV2 inoculation, pigs were monitored daily
and scored for severity of clinical respiratory disease,
with scores ranging from 0 to 6 (0 5 normal and 6 5
severe dyspnea and abdominal breathing).26 In addition,
pigs were evaluated daily for clinical signs of disease
including sneezing (score range from 0 [no sneezing] to 3
[severe persistent sneezing]), and jaundice. Rectal
temperature, wasting, and behavioral changes such as
lethargy were recorded daily. The pigs were weighed on
the day of PCV2 inoculation and on PID 7, 14, 21, 28,
and 35.
Quantification of PCV2
Extraction of DNA from sera obtained on the day of
PCV2 inoculation and on PID 7, 14, 21, 28, and 35 was
performed using the QIAamp DNA Mini Kit (Qiagen,
Valencia, CA). The DNA extracts were used for
quantification of the amount of PCV2 genomic DNA
by use of real-time PCR analysis.55
Necropsy
Necropsy was performed on half of the PCV2-
infected pigs of each breed at PID 21 (n 5 12 Duroc,
n 5 11 Landrace, n 5 11 Large White) and on the
remaining pigs at PID 35 (n 5 11 Duroc, n 5 eight
Landrace, n 5 10 Large White). In addition, 7 of 12
control pigs (two Duroc, three Landrace, and two Large
White pigs) were necropsied on PID 21, and 5 of 12 (one
Duroc, three Landrace, and one Large White pig) were
necropsied on PID 35. The total amount of macroscopic
lung lesions (0–100% of the lung affected),26 and size of
lymph nodes (score range from 0 to 3; 0 [normal], 1 [two
times the normal size], 2 [three times the normal size], 3
[four times the normal size]) were estimated.
Lungs were insufflated with fixative as described.26
Sections of lymph nodes (superficial inguinal, external
iliac mediastinal, tracheobronchial, mesenteric), tonsil,
thymus, ileum, kidney, colon, spleen, and liver were
collected at necropsy and fixed in neutral-buffered 10%
formalin and processed in routine manner for histologic
examination.
Histologic examination and immunohistochemical analysis
Microscopic lesions were evaluated in a blinded
manner. Lung sections were scored for presence and
severity of interstitial pneumonia ranging from 0 to 6 (0
5 normal; 6 5 severe diffuse).26 Sections of heart, liver,
kidney, ileum, and colon were evaluated for the presence
of lymphohistiocytic inflammation and were scored
from 0 5 none to 3 5 severe. Lymphoid tissues
including lymph nodes, tonsil, and spleen were evaluat-
ed for the presence of lymphoid depletion ranging from
0 5 normal to 3 5 severe histiocytic inflammation and
replacement of follicles ranging from 0 5 normal to 3 5
severe.54
Immunohistochemical detection of PCV2-specific
antigen was performed on formalin-fixed and paraffin-
embedded lymphoid tissue sections (lymph nodes
[superficial inguinal, external iliac mediastinal, tracheo-
bronchial, and mesenteric], tonsil, spleen, and thymus)
of all pigs and sections of intestine from selected pigs
using a rabbit polyclonal antiserum.67 Scoring for PCV2
antigen was done in blinded manner, and scores ranged
from 0 5 no signal to 3 5 .50% of the lymphoid
follicles containing cells with PCV2 antigen staining.54
Mean group score was determined for each tissue and
was compared among groups.
The overall PCV2-associated lesions were evaluated
as described.54 A combined scoring system for each
lymphoid tissue that ranged from 0 to 9 (lymphoid
depletion score 0–3; granulomatous inflammation score
0–3; PCV2-IHC score 0–3) was used. The scores (lesions
and PCV2-IHC) for the seven lymphoid tissues ([lymph
node pool multiplied by five] + [spleen] + [tonsil]) were
added together and divided by seven. The lymph node
pool consisted of one section each of tracheobronchial,
superficial inguinal, external iliac, mediastinal, and
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mesenteric lymph nodes. Pigs were grouped into four
categories on the basis of overall microscopic lymphoid
lesion scores: normal (score 5 0), mild (score 5 1–3),
moderate (score 5 4–6) and severe (score 5 7–9). The
mean treatment group lymphoid score was calculated
and compared among groups. A pig was diagnosed as
having microscopic lesions typical of PMWS if the mean
lymphoid microscopic lesion severity score was severe
(score 7–9) and if there was evidence of lymphohistio-
cytic inflammation in other organ systems.
Statistical analysis
The main outcome of interest in this study was
evaluation differences in PCV2 susceptibility among
breeds. Therefore, owing to the low number of sham-
inoculated control pigs, statistical analyses were limited
to PCV2-infected pigs. Summary statistics were calcu-
lated for all PCV2-infected pigs within each breed to
assess the overall quality of the data. Analysis of
variance (ANOVA) was used for cross-sectional assess-
ment of the average daily weight gain and nonrepeated
continuous measures. The significance level was P ,
0.05 followed by pairwise testing using the Tukey-
Kramer adjustment to identify the groups that were
different. Effect of sire or dam on the outcome was
tested by using the model: y 5 breeds + sires (breeds) +
dams (sires, breeds). To summarize and simplify the
clinical observations, response feature analysis and chi-
square testing was used. The clinical scores for each pig
were reduced to one weekly mean score, and the
resulting values were subjected to statistical analysis.
Daily rectal temperature data were analyzed with
multivariate ANOVA. Nonrepeated measures of nec-
ropsy and histopathologic data were assessed using
nonparametric Kruskal-Wallis ANOVA. If a nonpara-
metric ANOVA result was significant (P , 0.05),
Wilcoxon tests were used to assess the differences of
pairs of groups. Differences in incidence were evaluated
by using Fisher’s exact test.
A portion of the pigs within each breed had low
maternal antibodies at the time of PCV2 infection. To
evaluate influence of the antibody status on the results
regarding PCV2-associated lesions, maternal antibody-
negative and maternal antibody-positive pigs were
compared separately among breeds, and pairwise
Wilcoxon tests on outcomes of antibody-negative (S : P
,0.2) and antibody-positive (S : P $0.2) pigs within
each breed were done.
Results
Clinical disease
From PID 7 to 14, PCV2 infection was clinically
characterized by mild respiratory distress and,
occasionally, by sneezing. Mean respiratory scores
were higher in Landrace pigs for PID 7–14, but
were not significantly different (P . 0.05) among
breeds. Individual pigs of all three breeds had
periodically increased temperature; however, there
was no difference during the 21 days (P5 0.189) or
from PID 21 to PID 35 (P 5 0.372) in mean body
temperature among breeds nor was there a time-by-
group interaction.
From the day of PCV2 inoculation onward to
PID 35, mean6 SE weight gain was 633.76 32.8 g
for Duroc pigs, 763.8 6 49.5 g for Landrace pigs,
and 746.4 6 36.8 g for Large White pigs. The
weekly weight gain (data not shown) was not
significantly different (P . 0.05) among the breeds.
One Landrace pig developed persistent fever
.41.1uC from PID 14 onward and had to be
euthanized at PID 21, although it had been
randomly selected for the PID 35 necropsy group.
This pig gained only 6 g between PID 14 and 21,
which is consistent with wasting and clinical
PMWS in a growing pig. One other Landrace pig
had decreased average daily weight gain, compared
with that in the other Landrace pigs.
Serologic test results
At arrival, the majority of the pigs (65/75) had
maternal antibodies to PCV2, with mean PCV2-
ELISA S : P of 0.46 6 0.08 for Duroc pigs, 0.57 6
0.08 for Landrace pigs, and 0.43 6 0.07 for Large
White pigs. In the majority of the pigs (18/23
Duroc, 10/19 Landrace, 16/21 Large White),
maternal antibodies waned below the ELISA cutoff
(S : P ,0.2) prior to PCV2 inoculation (PID-
0 seronegative pigs). At the time of PCV2 in-
oculation, 5 of 23 Duroc, 9 of 19 Landrace, and 5
of 21 Large White pigs had low maternal antibody
levels (PID-0 seropositive pigs) with mean S : P of
0.22 6 0.00 for Duroc, 0.23 6 0.01 for Landrace,
and 0.24 6 0.01 for Large White pigs. As
expected,56 the passively acquired antibodies in
the noninfected control pigs decayed over time.
None of the control pigs seroconverted to PCV2
during the study. Most of the PCV2-infected pigs
seroconverted to PCV2 between PID 21 and PID
35. At PID 35, 7 of 11 Duroc, 6 of 8 Landrace, and
6 of 10 Large White pigs were positive for PCV2-
specific antibodies.
All pigs tested negative for PRRSV-specific anti-
bodies. The pigs had maternal antibodies to PPV that
decayed over time as expected.58 Indications of
seroconversion to PRRSV or PPV were lacking.
PCV2 viremia duration and genomic copy numbers
All serum samples obtained from the noninfect-
ed, control pigs were negative for PCV2-specific
nucleic acids, as tested by real-time PCR analysis.
In the PCV2-infected pigs, PCV2 viremia was
detected first at PID 7 in 13 of 23 Duroc, 14 of
19 Landrace, and in 9 of 21 Large White pigs.
Landrace pigs had significantly (P , 0.05) higher
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incidence of viremic pigs at PID 7, compared with
that for the Large White pigs. The majority of the
PCV2-infected pigs were viremic by PID 14 (21/23
Duroc, 17/19 Landrace, and 21/21 Large White
pigs). The duration of PCV2 viremia was based on
results from the PCV2-infected pigs (n 5 11 Duroc,
n 5 eight Landrace, and n 5 10 Large White pigs)
that remained in the study for the entire 35 days.
PCV2 viremia was determined to be 4.6 6
0.2 weeks in Duroc pigs (n 5 11), 4.3 6 0.6 weeks
in Landrace pigs (n 5 eight), and 4.2 6 0.4 weeks
in Large White pigs (n 5 10), and was not
significantly different (P 5 0.669) among breeds.
Mean copy number of PCV2 genomic DNA in
serum was not different (P . 0.05) among the
breeds at PID 7, 14, 21, 28, and 35.
Macroscopic lesions
There were no gross lesions in the noninfected
control pigs at the PID-21 or PID-35 necropsy
dates. At PID 21, 9 of 12 PCV2-inoculated Duroc,
10 of 11 PCV2-inoculated Landrace, and 11 of 11
PCV2-inoculated Large White pigs had gross
lymph node enlargement scores of 1.4 6 0.3, 2.0
6 0.3, and 1.6 6 0.2, respectively. In addition,
three Landrace pigs and one Duroc pig had
mottled-tan lungs that failed to collapse. The
Landrace pig that had to be euthanized at PID
21 (prior to scheduled necropsy at PID 35) was
emaciated, had a pale liver, and had moderate
edema throughout the stomach wall. At PID 35,
gross lesions in the PCV2-inoculated pigs were
limited to enlargement of lymph nodes in 9 of 11
Duroc (mean 1.8 6 0.3), 5 of 8 Landrace (mean 1.4
6 0.4), and 5 of 10 Large White (mean 0.9 6 0.3)
pigs.
Microscopic lesions and amount of PCV2-antigen
There were no microscopic lesions in any of the
control pigs (data not shown). A total of 7 of 63
PCV2-infected pigs did not have PCV2-associated
lymphoid lesions (overall score, 0) and 35 of 63 had
mild PCV2-associated lymphoid lesions (overall
score, 1–3). In 18 of 63 PCV2-infected pigs,
lymphoid lesions were moderate (overall score, 4–
6), and 3 of 63 pigs had severe lymphoid lesions
consistent with PMWS (overall score, 7–9)
(Table 1). If present, PCV2-associated lesions were
characterized by mild-to-severe lymphoid depletion
and mild-to-severe granulomatous inflammation in
lymphoid tissues associated with low to high
amounts of PCV2-antigen (Tables 2, 3). Landrace
pigs had significantly (P , 0.05) more severe
lymphoid depletion scores in tonsil at PID 21
(Table 2) and in the lymph node pool at PID 35,
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compared with those for Duroc and Large White
pigs (Table 3).
At PID 21, lymphohistiocytic hepatitis was mild
to moderate in 3 of 12 Duroc and 6 of 11 Landrace
pigs, and was mild in 6 of 11 Large White pigs.
Lymphohistiocytic myocarditis was moderate in 1
of 12 Duroc, mild to moderate in 4 of 11 Landrace,
and mild in 2 of 11 Large White pigs. Lymphohis-
tiocytic nephritis was mild in 3 of 12 Duroc pigs
and was mild to moderate in 3 of 11 Landrace and
3 of 11 Large White pigs.
At PID 35, lymphohistiocytic hepatitis was mild
to moderate in 4 of 11 Duroc pigs, and was mild in
4 of 8 Landrace and 1 of 10 Large White pigs.
Lymphohistiocytic myocarditis was mild in 1 of 11
Duroc, 2 of 8 Landrace, and 0 of 10 Large White
pigs. Mild lymphohistiocytic nephritis was ob-
served in 5 of 11 Duroc, 3 of 8 Landrace, and 3
of 10 Large White pigs.
Lung lesions were characterized by mild, focal-
to-diffuse, lymphohistiocytic interstitial pneumonia
with type-2 pneumocyte hypertrophy and hyper-
plasia in 5 of 12 Duroc and 4 of 11 Large White
pigs. Lymphohistiocytic interstitial pneumonia was
mild to moderate and focal to diffuse in 8 of 11
Landrace pigs at PID 21. At PID 35, mild, focal-to-
diffuse, lymphohistiocytic interstitial pneumonia
was present in 6 of 11 Duroc, 5 of 8 Landrace, and
5 of 10 Large White pigs.
Three Landrace pigs had microscopic lesions
consistent with PMWS, with severe lymphoid
depletion characterized by complete loss of the
follicular structure of all lymphoid tissues evaluat-
ed, severe histiocytic replacement of lymphoid
follicles, and high amounts of PCV2 antigen
associated with the lesions. These pigs also had
mild to moderate lymphohistiocytic inflammation
in other organ systems including heart, kidney,
liver, and thymus. There also was moderate to
severe granulomatous enteritis with moderate
numbers of multinucleated giant cells present in
Peyer’s patches of the ileum associated with
moderate to high amounts of PCV2-antigen.
Evaluation of the influence of passively acquired
antibodies on PCV2-associated lesions and viremia
among breeds
There was a total of 5 of 23 PID-0 seropositive
Duroc, 9 of 19 PID-0 seropositive Landrace, and 5
of 21 PID-0 seropositive Large White pigs on the
day of PCV2 inoculation. To delineate any possible
influence of low amounts of passively acquired
anti-PCV2 antibodies, the outcomes of the PID-
0 seronegative pigs of all breeds were compared
with each other. Similarly, the outcomes of the
PID-0 seropositive pigs among all breeds were
compared with each other. Separation of the
weekly weight gain data into PID-0 seronegative
and PID-0 seropositive pigs did not result in major
changes, compared with the weight gain data that
included PID-0 seronegative and PID-0 seropositive
pigs and was not significantly different (P . 0.05)
among the breeds (data not shown). Mean PCV2
genomic copy number for the PID-0 seronegative
pigs was not significantly (P. 0.5) different among
the breeds at PID 7, 14, 21, 28, and 35. Likewise,
no significant difference (P . 0.05) was observed
among breeds in mean PCV2 copy number for the
PID-0 seropositive pigs. At PID 21, PID-0 seroneg-
ative Landrace pigs had a significantly (P 5 0.01)
higher mean group overall lymphoid severity score,
compared with that for PID-0 seronegative Duroc
pigs (Table 1). The PID-0 seronegative Landrace
pigs had significantly (P , 0.5) more severe
depletion of the lymph nodes at PID 21 and 35
(Table 3), and significantly (P , 0.5) more severe
lymphoid depletion, inflammation, and PCV2
antigen associated with these lesions in tonsils at
PID 21, compared with that in PID-0 seronegative
Duroc and Large White pigs (Table 2). There was
a higher incidence of microscopic lung, liver, heart,
and kidney lesions in PID-0 seronegative, com-
pared with PID-0 seropositive pigs across breeds
(data not shown), but this difference was not
significant (P . 0.5).
In this study, the total incidence of microscopic
lesions consistent with PMWS was 15.8% (3 of 19)
for Landrace pigs, whereas none of the Duroc and
Large White pigs developed lesions consistent with
PMWS. When separated into PID-0 seronegative
and PID-0 seropositive, the PMWS incidence
increased to 30% (3 of 10) in PID-0 seronegative
Landrace pigs.
Within-breed influence of passively acquired antibodies on
PCV2-associated lesions and viremia
To further explore the possible influence of
presence of the amounts of passively acquired
PCV2 antibodies at the time of PCV2 inoculation
on PCV2 infection, outcomes of PID-0 seropositive
and PID-0 seronegative pigs within each breed
were compared with each other. At PID 14 and 21,
PID-0 seronegative Landrace pigs (n 5 10) had
significantly (P , 0.01) higher amounts of PCV2
nucleic acids in serum, compared with those in
PID-0 seropositive Landrace pigs (n 5 9). At PID-
21 necropsy, mean overall lymphoid severity score
was significantly (P , 0.002) higher in PID-
0 seronegative Landrace, compared with PID-
0 seropositive Landrace pigs (mean score: 6.2 6
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1.0 in PID-0 seronegative pigs [n 5 6] versus 1.1 6
0.3 in PID-0 seropositive pigs [n 5 5]) (Table 1).
There were no significant differences in Duroc or
Large White breeds between PID-0 seronegative
and PID-0 seropositive pigs, although PID-0 sero-
negative pigs had higher values (Table 1).
Evaluation of littermates of the PMWS-affected pigs
There was no litter or sire effect on the
development of PCV2-associated lesions. The three
Landrace pigs with microscopic lesions typical of
PMWS were from three litters, and two sires and
were housed in two rooms and three pens.
Comparison of data (serologic, overall lymphoid
lesions score) among the three Landrace pigs with
lesions consistent with PMWS and their littermates
is summarized in Table 4.
Discussion
The overall goal of this study was to conduct
a controlled experiment to investigate the influence of
host genetics on susceptibility to PCV2. We studied
Duroc, Landrace, and Large White pigs because
they were available from a single source. Today, all
three of these breeds are used extensively worldwide
in purebred and crossbred breeding programs.
A limited number of peer-reviewed manuscripts
have compared disease susceptibility in various pig
breeds. The muscle load of Sarcocystis miescheri-
ana bradyzoites after oral exposure was found to be
20 times higher in Pietrain, compared with Meishan
pigs.60 Compared with Meishan pigs, Large White
pigs were found to be more susceptible to infection
with pseudorabies virus59 or K88+ Escherichia
coli.15 Compared with Duroc and Meishan pigs,
Hampshire pigs developed significantly less severe
macroscopic lung lesions after experimental
PRRSV inoculation.27 Meishan pigs were found
to be highly resistant to K88ac+ E. coli-induced
disease, whereas there were both susceptible and
disease-resistant pigs within the Fengjjing and
Minzhu breeds.49
A cohort study was conducted on four PMWS-
affected farms to investigate a suspected decreased
susceptibility to PCV2-associated disease in Pie-
train pigs by manipulating the genetics via artificial
insemination. Half of the sows were inseminated
with Pietrain semen, whereas the remaining sows
received the semen that was typically used on these
farms.62 The PCV2-associated disease in the
Pietrain offspring did not differ from that observed
in other pigs on these farms in terms of PCV2
seroconversion, morbidity, and mortality. We did
not include Pietrain pigs in the study reported here
because the farm from which we purchased our
purebred pigs did not raise Pietrain pigs and we
believed it important to minimize confounding
factors (differences in environment, production
style, coinfection status) typical in pigs derived
from various sources.
All breeds of this study appeared to be equally
susceptible to PCV2 infection. There were no
significant differences in viremia duration, amount
of PCV2 genomic DNA copies, or anti-PCV2
antibody production among the breeds. However,
clinical disease and microscopic lesions consistent
with PMWS were only observed in the Landrace
pigs. The results indicate that the Landrace pigs of
this study were predisposed to progress from
subclinical PCV2 infection to clinical PMWS.
Table 4. Comparison of the Landrace pigs with lesions consistent with postweaning multisystemic wasting
syndrome (PMWS) and their littermates.
Pig No. PMWS Sire Dam
S : P* at
10 Days of
Age
S : P at Time of
PCV2 Infection
Age at PCV2
Infection
Overall Lymphoid
Severity Score
(classification){
Necropsy
(PID){
1 Yes A 1 0.025 0.032 51 days 8 (Severe) 21
2 No A 1 0.011 0.009 51 days 5 (Moderate) 21
3 No A 1 0.731 0.265 51 days 1 (Mild) 21
4 Yes A 2 0.255 0.175 48 days 8 (Severe) 21
5 No A 2 0.333 0.215 48 days 3 (Mild) 35
6 Yes B 3 0.568 0.192 48 days 9 (Severe) 211
7 No B 3 0.480 0.211 48 days 2 (Mild) 21
8 No B 3 0.567 0.173 48 days 3 (Mild) 21
* PCV2 ELISA sample-to-positive ratio (S : P $0.2 is considered a positive value [positive values are in bold-face type]).
{Mean value from seven lymphoid tissues (tonsil, spleen, five lymph nodes) ranging from 0–9 (lymphoid depletion 0–3.
inflammation 0–3; amount of PCV2 0–3); normal, score 5 0; mild score 5 1–3, moderate score 5 4–6, severe score 5 7–9.
{Postinoculation day.
1Originally selected for PID-35 necropsy.
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To the best of our knowledge, all other
confounding factors were similar across breeds in
this study. In the field, PMWS often resembles an
end-stage disease complex, and multiple pathogens
in addition to PCV2 often are detected.57 Experi-
mental coinfection of pigs with PCV2 and other
viruses such as PPV7,36,40,52 or PRRSV,2,32,64 or
bacteria such as M. hyopneumoniae54 has been
documented to enhance the amount of PCV2
genomic copies and PCV2-associated lesions and
to increase the incidence of PMWS. There may be
a variety of other known and unknown pathogenic
and nonpathogenic organisms that are able to
trigger progression of PCV2 infection to PMWS.
To account for this, we believed it important that
all pigs came from the same farm, were farrowed in
the same barn, and were transported together to
our research facilities, thereby equalizing the
microbiological flora across breeds as much as
possible.
Sex can be a confounding factor as well. There
are at least two studies that concluded male pigs
were more susceptible to development of PMWS
than were female pigs, and the authors thought this
might be attributable to castration and associated
secondary infections.11,61 Thus, in our study, we
used only female pigs to control for sex.
To our knowledge, all breeding herds are
infected with PCV2. We usually derive PCV2-
negative crossbred pigs for our experimental PCV2
inoculation trials by screening the entire batch of
dams scheduled to farrow during the desired
timeframe. We then select piglets from these sows
in the batch that have the lowest anti-PCV2
antibody levels.56 Owing to litter and sire restric-
tions and to the low number of purebred sows
within the same farrowing batch, such was not
possible in this study. We, therefore, did not screen
sows prior to purchase of the pigs, and a portion of
the pigs had high levels of maternal antibodies at
time of arrival. Compared with that in the other
two breeds, the Landrace pigs of this study had
higher levels of PCV2 antibodies at weaning and at
the time of PCV2 inoculation, but the difference
was not statistically significant (P . 0.5). Because
of the higher incidence and titer of maternal PCV2
antibodies, we increased the number of procedural
control Landrace pigs (six rather than three), which
decreased the number of experimentally infected
pigs within this breed. Because of budget and room
restrictions, experimental infection of the pigs was
started prior to complete waning of the maternal
antibody titer in these pigs.
We were also concerned about a possible but
unknown host age effect on PCV2 infection. At 5
to 8 weeks of age, 19 of 63 pigs (30.1%) still had low
levels of passively acquired antibodies to PCV2 at
the time of PCV2 inoculation. There were 47.4%
(9 of 19) of the experimentally infected Land-
race pigs that had low amounts of PCV2-specific
antibodies at the time of PCV2 inoculation,
compared with 21.8% (5 of 23) of the Duroc and
23.8% (5 of 21) of the Large White pigs. Landrace
piglets that had low but measurable maternal
antibodies at the time of PCV2 inoculation had
significantly (P , 0.05) reduced overall PCV2-
associated lesions, compared with Landrace piglets
that were seronegative at the time of PCV2
inoculation. All three Landrace pigs that developed
lesions consistent with PMWS were seronegative at
the time of PCV2 inoculation, as were the 18
Duroc, 16 Large White, and seven additional
Landrace pigs that did not develop PMWS. The
presence of anti-PCV2 antibodies has been docu-
mented to protect pigs from developing severe
PCV2-associated lesions.4,22 Our experimental re-
sults support this conclusion and indicate further
that only a portion of the anti–PCV2-negative pigs
are susceptible to PCV2-associated diseases. It has
been suggested that PCV2-ELISA S : P of 0.6
prevents PCV2 replication and development of
PMWS.33 On the basis of the results of our study,
even lower levels of passively acquired antibodies
are protective against development of severe PCV2-
associated lesions. This suggests that PCV2 vacci-
nation of breeding herds resulting in high passively
transferred antibody titer may be one way to
control PCV2-associated disease in growing pigs.
We were able to induce lesions consistent with
PMWS in 3 of 19 (15.8%) Landrace pigs, whereas we
were not able to induce PMWS in any of the Duroc
or Large White pigs. This is comparable to what is
seen in commercial crossbred swine production in
the field where the incidence of PMWS in affected
herds usually peaks with around 10% of the herd
affected, but may vary from as little as 4% to as high
as 30% in individual farms.1,28,43,61
In this study, we used a genetically well-
characterized PCV2 isolate20 that has been used
extensively in pig models. Previously, singular
PCV2 infection with the same isolate at a similar
cell culture passage and in approximately the same
dose as used in the purebred pigs of this current
study did not result in expression of clinical disease
or presence of microscopic lesions consistent with
PMWS in 264 crossbred pigs that were part of nine
studies.21–24,35,52–55 This further supports our con-
clusion that the purebred Landrace pigs used in this
study were more susceptible to PCV2-associated
diseases.
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It appears to be a common belief among some
producers and veterinarians that Landrace pigs are
more susceptible to infectious diseases in general;
however, reports describing experimental results
that substantiate this clinical impression are lacking
to our knowledge. On the basis of field observa-
tions, it has been suggested that Landrace pigs in
the UK appeared to be less affected by progressive
atrophic rhinitis than are Large White pigs.13
Landrace pigs are known to be predisposed to
type-III congenital tremor, which is attributable to
a monogenic sex-linked factor resulting in a de-
ficiency of oligodendrocytes in the spinal cord of
male Landrace pigs.29 Danish Landrace pigs are
thought to be the origin of dermatosis vegetans,
which is caused by a semilethal autosomal recessive
factor.14
More studies including larger numbers of Land-
race pigs from several lines and various geographic
locations are warranted to further investigate
a possible predisposition to PCV2-associated
PMWS in this breed. Genetic resistance may be
associated with a single gene, but is usually
associated with multiple genes. Another approach
may be to further study PMWS-affected pigs and
nonaffected littermates (who share at least 50% of
their genes in common) by gene array analysis to
possibly identify gene loci with differences in
expression that may be responsible for increased
susceptibility to PCV2-associated diseases. In
conclusion, despite its limited size, this work adds
to the body of evidence to explain differences in
clinical expression of PCV2-associated diseases
from farm to farm.
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